Tivity Health (TVTY) Given “Sell” Rating at Zacks Investment Research
Tivity Health (NASDAQ:TVTY)‘s stock had its “sell” rating restated by Zacks Investment Research in a report released on Saturday.
According to Zacks, “Tivity Health, Inc. provides health management services. The company offers services which include chiropractic services, physical therapy, occupational therapy, speech therapy, acupuncture, massage and complementary and alternative medicine services. Its network comprises SilverSneakers(R), Prime(R) Fitness and WholeHealth Living (TM). Tivity Health, Inc., formerly known as Healthways, Inc., is based in Franklin, Tennessee. “
A number of other brokerages also recently issued reports on TVTY. BidaskClub downgraded Tivity Health from a “buy” rating to a “hold” rating in a research report on Thursday. Barrington Research reiterated an “outperform” rating and issued a $40.00 target price (down previously from $46.00) on shares of Tivity Health in a research note on Tuesday, November 7th. ValuEngine lowered Tivity Health from a “buy” rating to a “hold” rating in a research note on Monday, October 2nd. SunTrust Banks set a $50.00 target price on Tivity Health and gave the stock a “buy” rating in a research note on Friday, October 27th. Finally, Oppenheimer increased their target price on Tivity Health from $47.00 to $50.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 1st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. Tivity Health currently has a consensus rating of “Buy” and a consensus price target of $46.25.
Tivity Health (NASDAQ:TVTY) last issued its quarterly earnings results on Thursday, October 26th. The company reported $0.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.10. The company had revenue of $137.70 million during the quarter, compared to the consensus estimate of $137.95 million. Tivity Health had a return on equity of 30.23% and a net margin of 11.45%. Tivity Health’s quarterly revenue was up 10.2% on a year-over-year basis. analysts anticipate that Tivity Health will post 1.6 EPS for the current year.
In other news, insider Mary Flipse sold 5,000 shares of the firm’s stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $48.11, for a total transaction of $240,550.00. Following the transaction, the insider now owns 45,167 shares in the company, valued at $2,172,984.37. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CAO Glenn Hargreaves sold 5,805 shares of the firm’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $45.15, for a total value of $262,095.75. Following the transaction, the chief accounting officer now owns 44,448 shares in the company, valued at approximately $2,006,827.20. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 875,892 shares of company stock worth $31,815,642. Insiders own 8.42% of the company’s stock.
Institutional investors have recently made changes to their positions in the company. Flinton Capital Management LLC increased its stake in shares of Tivity Health by 63.5% during the second quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock valued at $139,000 after buying an additional 1,360 shares during the period. Riverhead Capital Management LLC increased its stake in shares of Tivity Health by 69.7% during the second quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock valued at $142,000 after buying an additional 1,464 shares during the period. SG Americas Securities LLC purchased a new position in shares of Tivity Health during the third quarter valued at $210,000. Crossmark Global Holdings Inc. purchased a new position in shares of Tivity Health during the third quarter valued at $279,000. Finally, Piedmont Investment Advisors LLC purchased a new position in shares of Tivity Health during the second quarter valued at $290,000.
WARNING: This story was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States and international trademark & copyright law. The correct version of this story can be viewed at https://www.americanbankingnews.com/2018/01/06/tivity-health-tvty-given-sell-rating-at-zacks-investment-research.html.
Tivity Health Company Profile
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.